- Filed
- Mar 11, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 6, 2025 | 37.12M sh |
| Long Term Debt | Q3 2025 · Jan 31, 2025 | $2.44B |
| Long Term Debt | Q3 2025 · Apr 30, 2024 | $1.58B |
| Short Term Debt | Q3 2025 · Jan 31, 2025 | $243.76M |
| Short Term Debt | Q3 2025 · Apr 30, 2024 | $53.18M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $394.82M |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $206.48M |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $1.2B |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $953.47M |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $4.8B |
| Total Liabilities | Q3 2025 · Apr 30, 2024 | $3.33B |
| Current Assets | Q3 2025 · Jan 31, 2025 | $1.1B |
| Current Assets | Q3 2025 · Apr 30, 2024 | $829.85M |
| Total Assets | Q3 2025 · Jan 31, 2025 | $8.22B |
| Total Assets | Q3 2025 · Apr 30, 2024 | $6.35B |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 37.34M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 37.41M sh |
| Stock Repurchased | Q3 2025 · Jan 31, 2024 | $89.77M |
| Dividends Paid | Q3 2025 · Jan 31, 2024 | $46.98M |
| Capex | Q3 2025 · Jan 31, 2024 | $325.73M |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | $604.6M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $2.95B |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $2.9B |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $2.78B |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $2.66B |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $2.33 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $11.09 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $2.34 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $11.15 |
| Net Income | Q3 2025 · Jan 31, 2024 | $86.93M |
| Net Income | Q3 2025 · Jan 31, 2024 | $414.95M |
| Net Income | Q3 2025 · Oct 31, 2023 | $158.78M |
| Net Income | Q3 2025 · Jul 31, 2023 | $169.24M |
| Revenue | Q3 2025 · Jan 31, 2024 | $3.33B |
| Revenue | Q3 2025 · Jan 31, 2024 | $11.26B |